Prospective Outcomes of Guided Equator Overdentures

计划入组 40 人 · 首次发布于 2025 年 9 月 29 日

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

计划入组 32 人 · 首次发布于 2021 年 3 月 25 日

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity

计划入组 40 人 · 首次发布于 2019 年 9 月 23 日

Oxybenzone(Meijer)

C₁₄H₁₂O₃

BE-3-3-3-3

Indole-3-carbinol

C₉H₉NO

3-D Matrix Ltd.

Japan

River 3 Renal Corp.

United States

Immuno Cure 3 Limited

Itolizumab Shows Promising Results in Phase 2 Ulcerative Colitis Trial, Matching Adalimumab Efficacy

Primary Day-28 Analysis of a Phase 2/3 Open-Label Study

Sanofi's Rilzabrutinib Achieves Primary Endpoint in Phase 3 ITP Trial